Evidence map›Paper›PMID 39263938›Full record

ArticleActa obstetricia et gynecologica Scandinavica2024

Microvascular flow imaging of fibroids: A prospective pilot study.

Marissa Frijlingh, Barbara Stoelinga, Robert A de Leeuw, Wouter J K Hehenkamp, Jos W R Twisk, Thierry van den Bosch, Lynda J M Juffermans, Judith A F Huirne

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. A Novel Semi-Quantified Method for Grading Sonographic Severity of Adenomyosis and its Relation With Clinical Symptoms: An Observational Study.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Observational
  2. Article
  3. Article
  4. Review
  5. Microvascular flow imaging of fibroids: A prospective pilot study.Acta obstetricia et gynecologica Scandinavica · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marissa FrijlinghDepartment of Obstetrics and Gynecology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.ORCID 0000-0002-3483-3452
Barbara StoelingaDepartment of Obstetrics and Gynecology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
Robert A de LeeuwDepartment of Obstetrics and Gynecology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
Wouter J K HehenkampDepartment of Obstetrics and Gynecology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
Jos W R TwiskDepartment of Epidemiology and Biostatistics, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.
Thierry van den BoschDepartment of Obstetrics and Gynecology, University Hospital KU Leuven, Leuven, Belgium.
Lynda J M JuffermansDepartment of Obstetrics and Gynecology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
Judith A F HuirneDepartment of Obstetrics and Gynecology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionImaging fibroid vascularity may predict fibroid growth and aid to determine most appropriate therapy. Microvascular (MV) flow imaging is relatively new and is able to detect slow flow in small vessels. Data on feasibility, reproducibility, and reliability of MV-flow imaging in fibroids is lacking. The purpose of our study was to determine the reproducibility of MV-flow imaging and to explore this technique for clinical practice for assessing blood flow in fibroids. MATERIAL AND

methodsThirty patients with one or multiple fibroids (diameter 1.5-12.0 cm) were prospectively included. Transvaginal ultrasound scanning was performed in B-mode, 2D MV-Flow™, 2D and 3D power Doppler mode (HERA W10, Samsung) by two experienced gynecologists at a tertiary care clinic from February to December 2021. The primary outcome was intra- and interobserver agreement of the vascular index (VI) and color score (CS). The following parameters: '2D MV-flow VI', '3DPD VI', '2D MV-flow CS' and '2DPD CS' were measured offline in the center, pseudocapsule, and entire fibroid. Secondary offline outcomes for exploring 2D MV-flow for clinical practice, included (1) ability to discern vascular structures, (2) assessing the degree of vascularity via CS and calculating a VI, and (3) determining penetration depth of the ultrasound signal in both power Doppler and MV-flow imaging.

resultsAll scans of the 30 included patients were of sufficient quality to analyze. Inter- and intra-observer correlations of all studied parameters were good to excellent, both for 2D MV-flow and 2D power Doppler (intercorrelation coefficient 0.992-0.996). Using 2D MV-flow different vascular structures were visible in detail, in contrary to using 2D and 3D power Doppler. In significantly more fibroids central flow could be visualized using 2D MV-flow (63%) than with 2D power Doppler (13%, p = 0.001). Finally, penetration of the ultrasound signal was deeper using 2D MV-flow (3.92 cm) than with 2D power Doppler (2.95 cm, p = 0.001).

conclusionsUsing 2D MV-flow imaging for determining vascularity is highly reproducible. It has potential added value for clinical practice as it depicts detailed vascular structures and the degree of vascularity, especially in the center of the fibroid.

Indexed as

LeiomyomaMicrovesselsUterine NeoplasmsAdultFemaleHumansMiddle AgedPilot ProjectsProspective StudiesReproducibility of ResultsDopplerfibroidsmicrovascular flowsonographyultrasoundvascularity

Identifiers

PMID39263938
PMCPMC11502429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.